← All companies ← RDWR Manual REAX → ← RCUS Pharmaceuticals REGN →
RDY, Dr. Reddy's Laboratories Ltd
Dr. Reddy's makes medicines — in large part generic copies of drugs whose patents have lapsed, along with the active ingredients that go into them. It sells through wholesalers, pharmacy chains, and group purchasing organizations, with the United States a major market and India both its home market and its low-cost manufacturing base. The money comes from making a pill cheaply and selling it for more, with research, plant, and regulatory costs sitting in between.
Patents, Trademarks and Licenses We have filed and been issued num e rous patents in our principal areas of operations: Global Generics and Pharmaceutical Services and Active Ingredients.
For the pharmaceutical industry, the pricing dynamics of our products generally does not provide the opportunity to pass on such costs to customers.
The business
What it sells, where the money comes from, the kind of company it is.
The business in brief
read the 10-K →What this business is and what moves its needle, from its own SEC filings.
- What moves the needle
- The question that governs a generic maker is whether it owns a franchise or sells a commodity: once a patent lapses, copies multiply and the price of a given drug tends to fall, so the test is whether Dr. Reddy's stays the low-cost maker and refills its shelf with new approvals faster than old products erode. Much of its revenue is earned in foreign currencies while much of its cost is paid in rupees, so the spread rides on the exchange rate as well as on price. Watch the concentration of US buyers — a handful of wholesalers and purchasing groups — and the antitrust and product litigation that travel with that channel, since one regulatory or legal stumble at a key plant or product can swing a year. Whether any of this has held shows in the margins, the returns on capital, and the debt in the record below.
- Is it a good business?
- Return on capital has sat near the cost of capital (median 10%). By owner earnings: roughly 12% of revenue reaches owners as cash, consistently. This is price-taker territory, where the balance sheet and the cycle matter more than any multiple; the rest is in the 10-K.
Drafted from the company's filings and reviewed by hand; every number is shown in full in the sections below.
Where the money comes from
read the 20-F →Revenue spreads across 4 regions, the largest United States at 46%.
- United States46%₹149.4B
- Others29%₹94.4B
- India17%₹55.8B
- Russia8%₹26.0B
From the segment footnote of the company's own 20-F. Shares are of total revenue; the profit bar shows each segment's share of segment operating profit, before unallocated corporate costs.
The record
Ten years of arithmetic, read across the cycle.
The record, 2016–2025
realized figures from each filing · older years to the left| 2016’16 | 2017’17 | 2018’18 | 2019’19 | 2020’20 | 2021’21 | 2022’22 | 2023’23 | 2024’24 | 2025’25 | TTMTTMMar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| ₹154.7B | ₹140.8B | ₹142.0B | ₹153.9B | ₹174.6B | ₹189.7B | ₹214.4B | ₹245.9B | ₹279.2B | ₹325.5B | ₹325.5B | RevenueRevenue |
| 60% | 56% | 54% | 54% | 54% | 54% | 53% | 57% | 59% | 58% | 58% | Gross marginGross mgn |
| ₹29.6B | ₹13.5B | ₹11.9B | ₹20.9B | ₹16.0B | ₹24.3B | ₹29.5B | ₹57.1B | ₹67.7B | ₹71.8B | ₹71.8B | Operating incomeOp. inc. |
| 19.1% | 9.6% | 8.4% | 13.6% | 9.2% | 12.8% | 13.7% | 23.2% | 24.3% | 22.1% | 22.1% | Operating marginOp. mgn |
| ₹20.0B | ₹12.0B | ₹9.8B | ₹18.8B | ₹19.5B | ₹17.2B | ₹23.6B | ₹45.1B | ₹55.7B | ₹56.5B | ₹56.5B | Net incomeNet inc. |
| 26% | 18% | 32% | 16% | -8% | 35% | 27% | 25% | 23% | 26% | 26% | Effective tax rateTax rate |
| Cash flow & returns | |||||||||||
| ₹41.2B | ₹21.5B | ₹18.0B | ₹28.7B | ₹29.8B | ₹35.7B | ₹28.1B | ₹58.9B | ₹45.4B | ₹46.4B | ₹46.4B | Operating cash flowOp. cash |
| ₹10.3B | ₹11.3B | ₹11.7B | ₹12.2B | ₹12.5B | ₹12.8B | ₹11.8B | ₹12.6B | ₹14.8B | ₹17.1B | ₹11.7B | DepreciationDeprec. |
| ₹11.0B | (₹1.8B) | (₹3.5B) | (₹2.3B) | (₹2.1B) | ₹5.7B | (₹7.3B) | ₹1.2B | (₹25.1B) | (₹27.2B) | (₹21.8B) | Working capital & otherWC & other |
| ₹12.0B | ₹12.3B | ₹9.3B | ₹7.0B | ₹4.8B | ₹9.7B | ₹14.7B | ₹11.3B | ₹16.4B | ₹27.5B | ₹27.5B | CapexCapex |
| 7.8% | 8.7% | 6.5% | 4.5% | 2.8% | 5.1% | 6.8% | 4.6% | 5.9% | 8.4% | 8.4% | Capex / revenueCapex/rev |
| ₹29.2B | ₹9.2B | ₹8.7B | ₹21.7B | ₹25.0B | ₹26.0B | ₹13.4B | ₹47.6B | ₹29.0B | ₹29.4B | ₹34.7B | Owner earningsOwner earn. |
| 18.9% | 6.6% | 6.2% | 14.1% | 14.3% | 13.7% | 6.3% | 19.3% | 10.4% | 9.0% | 10.7% | Owner earnings marginOE mgn |
| ₹29.2B | ₹9.2B | ₹8.7B | ₹21.7B | ₹25.0B | ₹26.0B | ₹13.4B | ₹47.6B | ₹29.0B | ₹18.9B | ₹18.9B | Free cash flowFCF |
| 18.9% | 6.6% | 6.2% | 14.1% | 14.3% | 13.7% | 6.3% | 19.3% | 10.4% | 5.8% | 5.8% | Free cash flow marginFCF mgn |
| ₹4.1B | ₹3.4B | ₹4.0B | ₹4.0B | ₹3.9B | ₹4.1B | ₹4.1B | ₹5.0B | ₹6.6B | ₹6.7B | ₹6.7B | Dividends paidDiv. paid |
| ₹0 | ₹15.7B | ₹0 | ₹0 | ₹474M | ₹1.2B | ₹0 | — | — | — | — | BuybacksBuybacks |
| — | 7% | 5% | 10% | 9% | 8% | 10% | 18% | 18% | 15% | 15% | ROICROIC |
| 16% | 10% | 8% | 13% | 13% | 10% | 12% | 20% | 20% | 17% | 17% | Return on equityROE |
| 12% | 7% | 5% | 11% | 10% | 8% | 10% | 17% | 17% | 15% | 15% | Retained to equityRetained/eq |
| Balance sheet | |||||||||||
| — | ₹18.1B | ₹21.0B | ₹24.8B | ₹25.7B | ₹34.6B | ₹44.4B | ₹61.8B | ₹81.5B | ₹57.9B | ₹57.9B | Cash & investmentsCash+inv |
| — | ₹38.1B | ₹40.6B | ₹39.9B | ₹50.3B | ₹49.6B | ₹66.8B | ₹72.5B | ₹80.3B | ₹90.4B | ₹90.4B | ReceivablesReceiv. |
| — | ₹28.5B | ₹29.1B | ₹33.6B | ₹35.1B | ₹45.4B | ₹50.9B | ₹48.7B | ₹63.6B | ₹71.1B | ₹71.1B | InventoryInvent. |
| — | ₹13.4B | ₹16.1B | ₹14.6B | ₹16.7B | ₹23.7B | ₹25.6B | ₹26.4B | ₹30.9B | ₹35.5B | ₹35.5B | Accounts payablePayables |
| — | ₹53.2B | ₹53.7B | ₹58.9B | ₹68.7B | ₹71.3B | ₹92.1B | ₹94.7B | ₹112.9B | ₹126.0B | ₹126.0B | Operating working capitalOper. WC |
| — | ₹100.4B | ₹109.6B | ₹114.5B | ₹130.4B | ₹148.2B | ₹181.9B | ₹204.3B | ₹248.0B | ₹250.1B | ₹250.1B | Current assetsCur. assets |
| — | ₹85.0B | ₹69.7B | ₹59.7B | ₹72.8B | ₹83.4B | ₹94.0B | ₹85.8B | ₹96.0B | ₹130.4B | ₹130.4B | Current liabilitiesCur. liab. |
| — | 1.2× | 1.6× | 1.9× | 1.8× | 1.8× | 1.9× | 2.4× | 2.6× | 1.9× | 1.9× | Current ratioCurr. ratio |
| — | ₹3.8B | ₹3.9B | ₹3.9B | ₹4.0B | ₹4.6B | ₹4.4B | ₹4.2B | ₹4.3B | ₹11.8B | ₹11.8B | GoodwillGoodwill |
| — | ₹219.8B | ₹225.6B | ₹225.4B | ₹232.2B | ₹265.5B | ₹292.8B | ₹321.9B | ₹387.5B | ₹493.0B | ₹493.0B | Total assetsAssets |
| — | ₹49.0B | ₹50.6B | ₹34.1B | ₹17.7B | ₹29.4B | ₹32.8B | ₹8.7B | ₹18.7B | ₹45.9B | ₹45.9B | Total debtDebt |
| — | ₹30.9B | ₹29.6B | ₹9.4B | (₹8.0B) | (₹5.1B) | (₹11.5B) | (₹53.1B) | (₹62.8B) | (₹12.0B) | (₹12.0B) | Net debt / (cash)Net debt |
| 6.0× | 17.3× | 14.6× | 18.0× | 16.3× | 25.0× | 30.8× | 40.0× | 39.6× | 25.4× | 25.4× | Interest coverageInt. cov. |
| ₹128.3B | ₹124.0B | ₹126.5B | ₹140.2B | ₹155.0B | ₹173.1B | ₹190.5B | ₹231.0B | ₹280.6B | ₹333.4B | ₹333.4B | Shareholders’ equityEquity |
| Per share | |||||||||||
| 853M | 833M | 829M | 830M | 829M | 829M | 829M | 830M | 832M | 833M | 833M | Shares out (diluted)Shares |
| ₹181.42 | ₹168.99 | ₹171.28 | ₹185.46 | ₹210.67 | ₹228.80 | ₹258.49 | ₹296.18 | ₹335.55 | ₹390.82 | ₹390.97 | Revenue / shareRev/sh |
| ₹23.47 | ₹14.45 | ₹11.83 | ₹22.66 | ₹23.53 | ₹20.79 | ₹28.42 | ₹54.29 | ₹66.93 | ₹67.88 | ₹67.91 | EPS (diluted)EPS |
| ₹34.28 | ₹11.08 | ₹10.54 | ₹26.22 | ₹30.16 | ₹31.31 | ₹16.21 | ₹57.28 | ₹34.89 | ₹35.26 | ₹41.70 | Owner earnings / shareOE/sh |
| ₹34.28 | ₹11.08 | ₹10.54 | ₹26.22 | ₹30.16 | ₹31.31 | ₹16.21 | ₹57.28 | ₹34.89 | ₹22.72 | ₹22.73 | Free cash flow / shareFCF/sh |
| ₹4.82 | ₹4.07 | ₹4.81 | ₹4.82 | ₹4.72 | ₹5.00 | ₹5.00 | ₹6.00 | ₹7.99 | ₹8.00 | ₹8.00 | Dividends / shareDiv/sh |
| ₹14.09 | ₹14.74 | ₹11.20 | ₹8.38 | ₹5.85 | ₹11.75 | ₹17.68 | ₹13.64 | ₹19.72 | ₹33.02 | ₹33.03 | Cap. spending / shareCapex/sh |
| ₹150.50 | ₹148.87 | ₹152.50 | ₹169.00 | ₹187.00 | ₹208.70 | ₹229.71 | ₹278.24 | ₹337.21 | ₹400.25 | ₹400.40 | Book value / shareBVPS |
Share counts before 2023 are restated ×5 for a stock split, so per-share figures sit on one basis.
| 9-yr | 5-yr | |
|---|---|---|
| Revenue / share | +8.9%/yr | +13.2%/yr |
| Owner earnings / share | +0.3%/yr | +3.2%/yr |
| EPS | +12.5%/yr | +23.6%/yr |
| Dividends / share | +5.8%/yr | +11.1%/yr |
| Capital spending / share | +9.9%/yr | +41.4%/yr |
| Book value / share | +11.5%/yr | +16.4%/yr |
The record, charted
FY2016–2025Each measure over its full record; the current point and the worst year marked. Share counts on the current split basis.
Owner earnings vs. net income
Owner earningsNet incomeThe accountant's number, and the cash an owner can take; the gap is the tell.
Where the cash went
ReinvestBuybacksDividendsAcquisitionsRetainedEach year's operating cash, by what management did with it: the mix, and how it drifts.
Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.
In fiscal 2025 the business earned ₹29.4B of owner earnings, the operating cash left after the ₹17.1B it takes just to hold its position. It put ₹10.4B more into growth; free cash flow, after that spending, was ₹18.9B.
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Reported net income | ₹56.5B | ₹55.7B | ₹45.1B | ₹23.6B | ₹17.2B |
| Depreciation & amortizationnon-cash charge added back | +₹17.1B | +₹14.8B | +₹12.6B | +₹11.8B | +₹12.8B |
| Working capital & othertiming of cash in and out, other non-cash items | −₹27.2B | −₹25.1B | +₹1.2B | −₹7.3B | +₹5.7B |
| Cash from operations | ₹46.4B | ₹45.4B | ₹58.9B | ₹28.1B | ₹35.7B |
| Maintenance capital expenditurethe spending needed just to hold position and volume | −₹17.1B | −₹16.4B | −₹11.3B | −₹14.7B | −₹9.7B |
| Owner earnings | ₹29.4B | ₹29.0B | ₹47.6B | ₹13.4B | ₹26.0B |
| Growth capital expenditurediscretionary; spent to get bigger, not to stand still | −₹10.4B | — | — | — | — |
| Free cash flow | ₹18.9B | ₹29.0B | ₹47.6B | ₹13.4B | ₹26.0B |
| Owner-earnings marginowner earnings ÷ revenue | 9% | 10% | 19% | 6% | 14% |
Owner earnings is the cash an owner could pull out without starving the business: operating cash less the maintenance capital it must spend to hold its position (here about ₹17.1B, roughly its depreciation, the rate its assets wear out). The other ₹10.4B of its capital spending is growth it chose, not upkeep it owed; charged only with the maintenance it must do, the business earns well more than the year's free cash flow shows.
Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.
Quality & stewardship
Returns, the balance sheet, capital allocation, and pay.
Owner’s Scorecard
Will it survive?
- Can it pay its interest? 25.4×ComfortableOperating income ₹71.8B ÷ interest expense ₹2.8B
What this means
Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.
- Net cashCash ₹14.7B + ST investments ₹43.3B − debt ₹45.9B
What this means
Cash and short-term investments exceed every dollar of debt by ₹12.0B, on net the company owes nothing, and can act from strength when others can't. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.
- Long (60+ days)DSO 101 + DIO 192 − DPO 96 days
What this means
Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.
Is it a good business?
- Solid through the cycle9-yr median, range 5%–18%; 15% latest = NOPAT ₹53.4B ÷ invested capital ₹364.6BIndustry peers: median 19%
What this means
The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 9 years (it ran 15% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.
- Solid through the cycle10-yr median margin, range 6%–19%; latest ₹34.7B = operating cash ₹46.4B − maintenance capex ₹11.7BIndustry peers: median 23%
What this means
What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 11% of revenue this year, a 10% median across 10 years. It chose to put ₹15.8B more into growth, so free cash flow this year was ₹18.9B — the gap is investment, not weakness.
- Mostly cash-backedCash from ops ₹46.4B ÷ net income ₹56.5B
What this means
How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.
How is the cash used?
- Reinvests most of itDividends + buybacks ₹6.7B ÷ Owner Earnings ₹34.7B
What this means
Of ₹34.7B Owner Earnings, ₹6.7B (19%) went back to shareholders, ₹6.7B dividends, ₹0 buybacks. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does.
- Investing or harvesting? 2.35×ExpandingCapex ₹27.5B ÷ depreciation ₹11.7B
What this means
Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.
Graham’s defensive tests · 4 of 5 met
Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.
- Adequate size —Revenue ≥ $2B (a dollar floor) · ₹325.5B
What this means
Big enough to weather a storm. Graham's floor is a dollar figure — about $2B of revenue as a conservative modern stand-in. This company reports in its home currency and we carry no exchange rate, so we show the figure and leave the size bar for you to apply rather than convert it with a number we don't have.
- Strong liquidity NearCurrent ratio ≥ 2× · 1.92×
What this means
Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.
- Conservative debt PassDebt ≤ working capital · ₹45.9B vs ₹119.7B WC
What this means
Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.
- Earnings stability PassA profit every year (10-yr record) · no losses
What this means
Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.
- Dividend record PassUninterrupted dividends · paid every year (10)
What this means
An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.
- Earnings growth PassEarnings +33% over the record · +276%
What this means
At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.
- Moderate price —P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
What this means
Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are ₹62.82/share (latest year ₹67.75), the averaged base the calculator's gate runs on, and book value is ₹399.43/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.
Durability & moat, 2016–2025
Whether the record’s returns held, and what the capital reinvested earned.
- Profitable years 10 of 10
What this means
Never lost money over the record, the earnings stability Graham insisted on.
- Return on capital ≥ 15% 2 of 9 yrs
What this means
A moat shows up as a high return on invested capital that holds year after year, not one good vintage.
- Operating margin 12% → 23% (3-yr avg ends)
In the filing’s words The margin widened even though the filing names price competition — the gain came from volume or cost, not pricing power. Read where.
What this means
Through the cycle the operating margin widened — about 12% early to 23% lately, median 14% — pricing power intact or improving.
- Reinvestment, incremental ROIC 29%
What this means
Every extra dollar the business reinvested came back at a high incremental return — the lens GBM read for a moat that reinvests rather than merely harvests. The record and the 10-K are where you check whether the rate holds.
- Owner earnings growth +5%/yr
What this means
Owner earnings grew about 5% a year over the record.
- Worst year 2018 · 8.4% op. margin
What this means
Stayed profitable even in its hardest year, the resilience that survives recessions.
- Dividend record rising
What this means
Paid and raised the dividend across the record, the continuity Graham prized.
Does AI threaten the moat?
Low contestabilityThe moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.
Its FY2026 10-K names artificial intelligence as a competitive threat, in language that was not in the prior year's filing.
“The increasing adoption of AI and generative AI technologies subjects us to evolving operational, regulatory, and competitive risks.”
AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat, and the company is using it that way.
Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.
All figures as filed; the source filing is linked above.
Current Position
as of fiscal year-end, Mar 31, 2025Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.
- Cash & short-term investments₹57.9B
- Receivables₹90.4B
- Inventory₹71.1B
- Other current assets₹30.7B
- Debt due within a year₹38.0B
- Accounts payable₹35.5B
- Other current liabilities₹56.8B
From the company's latest filing.
How the cash was used, 2016–2025
Over the record, the business generated ₹353.9B of operating cash; how management split it reads as a balanced allocator, splitting cash between the business, owners, and the balance sheet.
- Reinvested₹125.0B · 35%
- Dividends₹46.0B · 13%
- Buybacks₹17.4B · 5%
- Retained (debt / cash)₹165.5B · 47%
- Returned to owners₹63.3B
26% of the owner earnings the business produced over the span, ₹46.0B as dividends and ₹17.4B as buybacks.
- Average price paid for buybacks—
Buybacks ran ₹17.4B over the span, but the filings don't tag the share count needed to deduce the average price paid.
- Net change in share count−2.4%
The diluted count fell from 853M to 833M, so the buybacks outran the stock issued to staff.
- Dividend record₹8.00/sh
Paid in 10 of the years on record, the per-share dividend growing about 6% a year. It was cut at least once along the way.
- Return on what it retained9%
Of the earnings it kept rather than paid out (₹214.9B over the span), annual owner earnings (first three years vs last three) grew ₹19.6B, so each retained ₹1 added about 0.09 of yearly owner earnings. Buffett's test, run on owner earnings instead of market value.
Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.
Acquisitions & goodwill
from the balance sheet & the 10-year cash-flow recordGoodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.
None written down over the record; the goodwill is still carried at full cost. That is the deals holding their value on the books so far; whether they keep doing so is the test an owner watches, since the write-down, when it comes, is the admission the price was too high.
Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and write-downs summed across the 10-year record, from the company's own filings.
Inverting the record
Invert: instead of why Dr. Reddy's Laboratories Ltd is a good business, the question is what would make owning it a mistake, and whether those marks are in the record. Disconfirming tests across 2016–2025.
None of the 3 tests turned up a mark; each came back clean. A clean panel says only that these particular ways of being wrong are not written into the record.
- Is it less profitable than it was?
- Did the share count rise anyway?
- Did reported profit become cash?
Each test is read from the filings and is noisy alone; a flag can mark a cyclical trough or a year of heavy investment as easily as a problem. The filing says which.
Peers, Pharmaceuticals
The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.
| Company | Revenue | Gross margin | Op. margin | ROIC | Owner earn. margin |
|---|---|---|---|---|---|
| RDYDr. Reddy's Laboratories Ltd | ₹325.5B | 55% | 13.7% | 10% | 12% |
| JNJJohnson & Johnson | $94.2B | 67% | 23.8% | 22% | 23% |
| LLYEli Lilly and Company | $65.2B | 78% | 24.0% | 27% | 20% |
| MRKMerck & Company Inc. Common Stock (new) | $65.0B | 70% | 25.9% | 19% | 21% |
| PFEPfizer Inc. | $62.6B | 75% | 26.1% | 11% | 28% |
| ABBVAbbVie Inc. | $61.2B | 70% | 28.0% | 21% | 38% |
| BMYBristol-Myers Squibb Company | $48.2B | 72% | 18.9% | 12% | 28% |
| ABTAbbott Laboratories | $44.3B | 56% | 15.8% | 11% | 17% |
| Group median | — | 70% | 23.9% | 15% | 22% |
The price
What a price has to assume.
What the price implies
reverse-DCFEnter the home-market price, not the US ADR quote. Dr. Reddy's Laboratories Ltd reports in INR, and every figure here (owner earnings, book value, the share count) is on that INR, ordinary-share basis. Enter the price on the same basis: the local-exchange quote per ordinary share in INR. A US ADR price in dollars bundles the ADR-to-ordinary ratio and the exchange rate, so it will not reconcile with these figures and would throw the multiple off.
Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Dr. Reddy's Laboratories Ltd has delivered.
Through the cycle, Dr. Reddy's Laboratories Ltd earns about ₹39.6B on its 12.2% median owner-earnings margin. This year’s 10.7% margin runs in line with that. Normalize, below, values the price on that through-cycle figure rather than the latest year.
—
9.0% = the 4.55% 10-year Treasury (Jul 15, 2026) + 4.45 points of equity premium. The rate you require is yours to set.
Enter a price above to run it.
A dated snapshot of the price you typed, the assumptions you set, and what the page showed for them. A snapshot is never edited after it is saved. Your notebook is yours alone — the commitment states what is stored and what we will never do.
Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.
Prefilled with the 10-year Treasury (4.55%, as of Jul 15, 2026). Edit it for today’s exact figure, or a AAA corporate yield.
Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.
Free cash flow ₹18.9B on 835M shares outstanding, per the 20-F cover, as of 2026-03-31; net cash ₹12.0B. The base is the latest year by default; Normalize values it on the through-cycle median owner-earnings margin (to avoid paying on a peak year). Net of stock comp treats option pay as the expense it is. Capex (₹27.5B) runs well above depreciation (₹11.7B), so this is a build-out; Steady-state swaps total capex for maintenance (≈ depreciation), lifting the base to about ₹34.7B, the cash it would throw off if it stopped expanding. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.
Manual order: ← RDWR its page in the Manual REAX →
Industry order: ← RCUS the Pharmaceuticals chapter REGN →